Cached score snapshot

US.MRNA · Moderna

110分制 56/110；5D動能v2 31/50；排序分 87/160

Back to ranking Open volume snapshot

Ranking score 87/160

Main score 56/110

5D momentum v2 31/50

Rank #40

Setup grade B 75.3

Score breakdown

觀望

Elevated database-backfill

Score and price trend

B 75.3 lift 1.79x · Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.706 · anchors 120	+1.93%	-1.03% / +5.91%	66.7%	5.8%	Actual -7.23% · vs median -9.16% · inside 25-75 band
30D observation	+8.88%	-2.10% / +27.41%	70%	19.2%	Actual +12.24% · vs median +3.36% · inside 25-75 band
Historical projection 10D n=160	+1.65%	-1.20% / +5.21%	63.1%	7.5%	Actual -13.74% · vs median -15.39% · inside 25-75 band

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-02-12 → 2026-06-24 · 91 archived points · 2 Improving turn signal · 7 Deteriorating signal · 4 Exit review signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 87

Display grade 觀望

Model version cursor_18_27_news_v2_160

Main score 56/110 (觀望)

5D momentum v2 31/50 (強)

Score with momentum v2 87/160 (低排序)

Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 4 sections

Market inputs

Bar count 220

ma20 50.637

ma50 51.5987

close 54.35

prevClose 48.54

avgVolume20 6861200

volumeRatio 3.05

changePercent 11.97

Metrics snapshot

close 54.35

volume 20925900

changePercent 11.97

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 56/110

Main rating 觀望

5D momentum v2 31/50

Score with momentum v2 87/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.7/5 · 較差

Dimension score 2.7/5

Dimension grade 較差

No sub-item breakdown recorded.

資金流 — 11.6/20 · 較差

Dimension score 11.6/20

Dimension grade 較差

No sub-item breakdown recorded.

市場環境 — 10.6/15 · 良好

Dimension score 10.6/15

Dimension grade 良好

No sub-item breakdown recorded.

催化劑 — 2/20 · 較差

Dimension score 2/20

Dimension grade 較差

No sub-item breakdown recorded.

風險管理 — 5.1/10 · 較差

Dimension score 5.1/10

Dimension grade 較差

No sub-item breakdown recorded.

技術信號 — 21/30 · 良好

Dimension score 21/30

Dimension grade 良好

No sub-item breakdown recorded.

情緒分析 — 3/10 · 較差

Dimension score 3/10

Dimension grade 較差

No sub-item breakdown recorded.

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 31/50

ret_5d 0.1979

raw_total 31

vcp_bonus 0

ret_points 18

vol_points 8

breakout_points 0

Risk management

level Elevated

reason risk management score >= 5/10

position

score 1.1

details

atrPct 6.2889

turnoverUsdM 1137.3227

liquidityPoints 0.8

volatilityPoints 0.3

rrPoints 1.4

stopLevels

symbol US.MRNA

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 47.514

strength_details

ma_score 1

atr_score 1

rsi_score 1

macd_score 2.5

volume_score 3

market_adjustment 1

risk_reward_ratio 1.1

stop_loss_percent 12.6

take_profit_price 62.0348

target_multiplier 1.9

technical_strength 1.78

take_profit_percent 14.1

positionPoints 1.1

stopLossPoints 0.6

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.2

stopLossPercent 12.5777

diversificationPoints 2

Raw calculation JSON

{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 6.28886844526219,
        "turnoverUsdM": 1137.322665,
        "liquidityPoints": 0.8,
        "volatilityPoints": 0.3
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.MRNA",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 47.514,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 1,
        "rsi_score": 1,
        "macd_score": 2.5,
        "volume_score": 3
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 12.6,
      "take_profit_price": 62.0348,
      "target_multiplier": 1.9,
      "technical_strength": 1.78,
      "take_profit_percent": 14.1
    },
    "positionPoints": 1.1,
    "stopLossPoints": 0.6,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 12.57773689052438,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 87,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 56,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 31
  },
  "market": {
    "ma20": 50.637,
    "ma50": 51.5987,
    "close": 54.35,
    "prevClose": 48.54,
    "avgVolume20": 6861200,
    "volumeRatio": 3.05,
    "changePercent": 11.97
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 220,
  "momentum": {
    "max": 50,
    "result": 31,
    "details": {
      "ret_5d": 0.19792814635221512,
      "raw_total": 31,
      "vcp_bonus": 0,
      "ret_points": 18,
      "vol_points": 8,
      "breakout_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 56,
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.7,
      "資金流": 11.6,
      "市場環境": 10.6,
      "情緒分析": 3,
      "技術信號": 21,
      "風險管理": 5.1
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差"
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差"
      },
      "市場環境": {
        "max": 15,
        "grade": "良好"
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差"
      },
      "技術信號": {
        "max": 30,
        "grade": "良好"
      },
      "風險管理": {
        "max": 10,
        "grade": "較差"
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ]
  }
}

Raw metrics JSON

{
  "close": 54.35,
  "volume": 20925900,
  "changePercent": 11.97
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.